Rosebud Bio
Industrializing organoids for drug discovery
San Francisco, United States · Founded 2020 · $870K raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Total Funding
- $870K
- Last Round
- $270K GrantAug 2023
- Rounds
- 2
About
Rosebud Biosciences is an early-stage biotech startup that models human genetic diseases using iPSC-derived organoids to discover and screen drugs for rare pediatric conditions. Their automated platform predicts drug efficacy and screens for off-target toxicities entirely in human tissue models, accelerating translational drug development. Founded in 2020 and backed by Y Combinator, the company targets the 95% of genetic diseases that still lack approved treatments.
Summary
Rosebud Bio is a Drug Discovery company based in San Francisco, United States, founded in 2020. It has raised $870K in total across 2 rounds, most recently a $270K Grant round in Aug 2023.
Funding History
Aug 2023
Sign up to see all 2 rounds
Seed through Grant — per-round amounts, valuations, and who invested in each round.
Similar Companies
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Databricks provides a unified data and AI platform that helps enterprises build and run applicati...
Stripe provides payments, billing, money-management, fraud-prevention, and identity tools that he...
Aramark delivers food, facilities-management, hospitality, refreshment, and supply-chain services...
Visma is a European provider of mission-critical enterprise resource planning software and servic...
BMC builds enterprise software that orchestrates workflows across cloud, mainframe, and hybrid en...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rosebud-bio"><img src="https://indexed.vc/api/badge/company/rosebud-bio" alt="Rosebud Bio on Indexed.vc" width="260" height="76" /></a>